| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700553 Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization |
| 04/20/2010 | US7700549 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 04/20/2010 | US7700544 Compositions and methods for treating atherosclerosis |
| 04/20/2010 | US7700523 zinc finger motifs are randomised in overlapping regions and to smart libraries incorporating limited directed randomisation at selected position |
| 04/20/2010 | US7700362 Method for screening therapeutic agents for disuse muscular atrophy using interaction between selected proteins and a polyubiquitin chain |
| 04/20/2010 | US7700361 Secretory or membrane protein expressed in skeletal muscles |
| 04/20/2010 | US7700353 Compositions and methods for inducing apoptosis in tumor cells |
| 04/20/2010 | US7700345 Exopolysaccharide hyper-producing cells unresponsive to modulator of bacterial exopolysaccharide biosynthesis |
| 04/20/2010 | US7700342 Lentiviral packaging constructs |
| 04/20/2010 | US7700339 Echinoderm Microtubule-Associated Protein-Like 4 (EML-4); Anaplastic Lymphoma Kinase (ALK); non-small cell lung carcinoma (NSCLC) |
| 04/20/2010 | US7700334 immobilization with control over the orientation of the attachment; efficient, not requiring the previous purification of the protein to be attached, and can be activated by UV-light; photolithography |
| 04/20/2010 | US7700322 provide alternative host cells comprising multiple copies of a gene of interest, which cells are devoid of antibiotic markers, for use in the industrial production of polypeptides in high yields |
| 04/20/2010 | US7700318 polypeptide comprising a TNF neutralizer domain, an IL-1 receptor antagonist domain, and a dimerization domain; rheumatoid arthritis or psoriasis |
| 04/20/2010 | US7700317 glycoprotein comprising the extracellular domain of a non-naturally occurring BAFF-R; BAFF (B-cell-activating factor of the TNF family); immunologic, autoimmune diseases, cancers, virus-associated diseases, renal, hypertensive diseases, conditions requiring immunosuppression, inflammation |
| 04/20/2010 | US7700316 CD109 nucleic acid molecules, polypeptides and methods of use |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700309 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tau |
| 04/20/2010 | US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700296 Kit comprising monoclonal antibodies directed against an epitope; determining level in serum for diagnosis of coronary atherosclerosis, vascular calcification, angiogenesis, diabetes |
| 04/20/2010 | US7700294 Method of isolating cytotoxic heterocomplex associated with multiple sclerosis |
| 04/20/2010 | US7700276 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents |
| 04/20/2010 | US7700132 Isolated material having an anti-organotrophic effect |
| 04/20/2010 | US7700120 Adjuvancy and immune potentiating properties of natural products of Onchocerca volvulus |
| 04/20/2010 | US7700119 85kDa neisserial antigen |
| 04/20/2010 | US7700117 Camp factor of Streptococcus uberis |
| 04/20/2010 | US7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane |
| 04/20/2010 | US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity |
| 04/20/2010 | US7700113 Inhibiting breast cancer cell growth by administering an intracellular domain of NOTCH2 |
| 04/20/2010 | US7700112 FSH beta mutants that are glycosilated at residues N55 and T57 |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700108 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 04/20/2010 | US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 04/20/2010 | US7700105 Methods of inducing IL-10 production |
| 04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
| 04/20/2010 | US7700103 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 04/20/2010 | US7700102 Stimulant immunology response; prevent infections |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
| 04/20/2010 | US7700091 Bacterium for use as vehicle for gene transport and transfer to preferential organs or tissues; tissue engineering and targeted somatic transgenesis |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | CA2417207C Dental products comprising bone growth enhancing peptide |
| 04/20/2010 | CA2377468C Peptide acceptor ligation methods |
| 04/20/2010 | CA2318486C Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 04/20/2010 | CA2287541C Regulatory system for inducible expression of genes with lambdoid promoters |
| 04/20/2010 | CA2212702C Mucosal vascular addressins and uses thereof |
| 04/20/2010 | CA2185349C Radiolabeled annexin-galactose conjugates |
| 04/20/2010 | CA2181433C Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/20/2010 | CA2155303C Treatment for insulin dependent diabetes |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/15/2010 | WO2010042799A2 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 04/15/2010 | WO2010042760A2 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
| 04/15/2010 | WO2010042751A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042749A2 Chimeric therapeutics, compositions, and methods for using same |
| 04/15/2010 | WO2010042747A2 Fgf21 mutants and uses thereof |
| 04/15/2010 | WO2010042743A2 Chimeric multiplexes, compositions, and methods for using same |
| 04/15/2010 | WO2010042741A1 Methods of making concentrated fibrinogen- and platelet containing compositions |
| 04/15/2010 | WO2010042654A2 Recombinant nell protein production |
| 04/15/2010 | WO2010042575A1 Transgenic plants with enhanced agronomic traits |
| 04/15/2010 | WO2010042548A2 Methods of treating inflammation |
| 04/15/2010 | WO2010042490A1 A single lentiviral vector system for induced pluripotent (ips) stem cells derivation |
| 04/15/2010 | WO2010042243A1 Tetranectin trimeri zing module truncation variants |
| 04/15/2010 | WO2010042225A2 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 04/15/2010 | WO2010042206A1 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 04/15/2010 | WO2010042145A1 Polymer conjugates of glp-2-like peptides |
| 04/15/2010 | WO2010041942A1 Improved env peptides and proteins |
| 04/15/2010 | WO2010041742A1 Method for introducing dota |
| 04/15/2010 | WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 |
| 04/15/2010 | WO2010041241A2 Hiv-1 integrase derived peptides and compositions |
| 04/15/2010 | WO2010041237A2 Cyclic v3 peptides for anti hiv-1 vaccine |
| 04/15/2010 | WO2010041145A2 Il-17-mediated transfection methods |
| 04/15/2010 | WO2010041138A2 Complex between human insulin and an amphiphilic polymer, and use of said complex for preparing a quick human insulin formulation |
| 04/15/2010 | WO2010040998A1 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 04/15/2010 | WO2010040847A2 Recombinant protein bodies as immunogen-specific adjuvants |
| 04/15/2010 | WO2010040845A1 Polypeptides having antimicrobial activity |
| 04/15/2010 | WO2010040830A1 Multiple n-methylated cyclic hexapeptides for treatment of neurogenic inflammation |
| 04/15/2010 | WO2010040756A1 Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6 |
| 04/15/2010 | WO2010040737A1 Epitopes derived from satb2 and uses thereof |
| 04/15/2010 | WO2010040538A1 Marker peptides for determining the occurrence of an inflammatory state in a subject |
| 04/15/2010 | WO2010040508A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | WO2010040446A1 Estrogen and anti-estrogen marker genes |
| 04/15/2010 | WO2010040362A1 Antibodies against rns-induced modified cytokines and uses thereof |
| 04/15/2010 | WO2010040305A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 04/15/2010 | WO2010040209A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | WO2010040204A1 Detection of granulosa-cell tumors |
| 04/15/2010 | WO2010022198A3 Rcc t cell receptors and related materials and methods of use |
| 04/15/2010 | WO2010016940A3 Analogues of glucose-dependent insulinotropic polypeptide |
| 04/15/2010 | WO2010012948A3 Combination of two genetic elements for controlling the floral development of a dicotyledonous plant, and use in detection and selection methods |
| 04/15/2010 | WO2010004052A3 Agonists of nr2f6 for immunosuppression |
| 04/15/2010 | WO2010003668A3 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 04/15/2010 | WO2010000854A3 New bacteriophage adhesion proteins |
| 04/15/2010 | WO2009152147A3 Compositions and methods for dengue virus (dv) treatment and vaccination |
| 04/15/2010 | WO2009135118A9 Lyme disease vaccine |
| 04/15/2010 | WO2009134670A3 New chimeric alpha-amylase variants |